Skip to content
← Full study record

NCT00622336 · OUTCOME

Duration of Response

A Companion Study for Studies THAL-MM-003, CC-5013-MM-009, and CC-5013-MM-010 for Subjects With Multiple Myeloma · Source last updated 2019-11-20

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
Up to 70 months

What was measured

Duration of response based on the Myeloma response determination criteria developed by Bladé et al 1998 and defined as time from the initial documented response (partial response or better) to confirmed disease progression, based on International Myeloma Working Group (IMWG) criteria.

Analysis population: Duration of response not analyzed per the sponsors decision.

Groups in this outcome

Lenalidomide 25mg

Lenalidomide 25mg by mouth (PO) daily on Days 1 to 21 in each 28 day cycle

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Lenalidomide 25mg0

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
denoms
  1. counts
    1. group Id
      OG000
      value
      0
    units
    Participants
description
Duration of response based on the Myeloma response determination criteria developed by Bladé et al 1998 and defined as time from the initial documented response (partial response or better) to confirmed disease progression, based on International Myeloma Working Group (IMWG) criteria.
groups
  1. description
    Lenalidomide 25mg by mouth (PO) daily on Days 1 to 21 in each 28 day cycle
    id
    OG000
    title
    Lenalidomide 25mg
population Description
Duration of response not analyzed per the sponsors decision.
reporting Status
POSTED
time Frame
Up to 70 months
title
Duration of Response
type
SECONDARY

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice